14-35402888-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020529.3(NFKBIA):​c.548-29G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 1,597,270 control chromosomes in the GnomAD database, including 25,578 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1639 hom., cov: 32)
Exomes 𝑓: 0.18 ( 23939 hom. )

Consequence

NFKBIA
NM_020529.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.415

Publications

13 publications found
Variant links:
Genes affected
NFKBIA (HGNC:7797): (NFKB inhibitor alpha) This gene encodes a member of the NF-kappa-B inhibitor family, which contain multiple ankrin repeat domains. The encoded protein interacts with REL dimers to inhibit NF-kappa-B/REL complexes which are involved in inflammatory responses. The encoded protein moves between the cytoplasm and the nucleus via a nuclear localization signal and CRM1-mediated nuclear export. Mutations in this gene have been found in ectodermal dysplasia anhidrotic with T-cell immunodeficiency autosomal dominant disease. [provided by RefSeq, Aug 2011]
NFKBIA Gene-Disease associations (from GenCC):
  • ectodermal dysplasia and immunodeficiency 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • ectodermal dysplasia and immune deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 14-35402888-C-T is Benign according to our data. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-35402888-C-T is described in CliVar as Benign. Clinvar id is 1260146.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.187 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKBIANM_020529.3 linkc.548-29G>A intron_variant Intron 3 of 5 ENST00000216797.10 NP_065390.1 P25963

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKBIAENST00000216797.10 linkc.548-29G>A intron_variant Intron 3 of 5 1 NM_020529.3 ENSP00000216797.6 P25963

Frequencies

GnomAD3 genomes
AF:
0.134
AC:
20306
AN:
152096
Hom.:
1640
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0610
Gnomad AMI
AF:
0.166
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.106
Gnomad EAS
AF:
0.0138
Gnomad SAS
AF:
0.148
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.189
Gnomad OTH
AF:
0.126
GnomAD2 exomes
AF:
0.141
AC:
34599
AN:
245658
AF XY:
0.146
show subpopulations
Gnomad AFR exome
AF:
0.0631
Gnomad AMR exome
AF:
0.0788
Gnomad ASJ exome
AF:
0.101
Gnomad EAS exome
AF:
0.0107
Gnomad FIN exome
AF:
0.153
Gnomad NFE exome
AF:
0.188
Gnomad OTH exome
AF:
0.159
GnomAD4 exome
AF:
0.177
AC:
255406
AN:
1445056
Hom.:
23939
Cov.:
29
AF XY:
0.176
AC XY:
126751
AN XY:
719858
show subpopulations
African (AFR)
AF:
0.0610
AC:
2018
AN:
33082
American (AMR)
AF:
0.0819
AC:
3642
AN:
44472
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
2766
AN:
26030
East Asian (EAS)
AF:
0.0175
AC:
691
AN:
39562
South Asian (SAS)
AF:
0.159
AC:
13686
AN:
85858
European-Finnish (FIN)
AF:
0.158
AC:
8359
AN:
53052
Middle Eastern (MID)
AF:
0.159
AC:
901
AN:
5656
European-Non Finnish (NFE)
AF:
0.195
AC:
213561
AN:
1097544
Other (OTH)
AF:
0.164
AC:
9782
AN:
59800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
10594
21187
31781
42374
52968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7332
14664
21996
29328
36660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.133
AC:
20309
AN:
152214
Hom.:
1639
Cov.:
32
AF XY:
0.130
AC XY:
9677
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0611
AC:
2538
AN:
41524
American (AMR)
AF:
0.105
AC:
1606
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.106
AC:
367
AN:
3472
East Asian (EAS)
AF:
0.0139
AC:
72
AN:
5192
South Asian (SAS)
AF:
0.148
AC:
714
AN:
4830
European-Finnish (FIN)
AF:
0.159
AC:
1687
AN:
10604
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.189
AC:
12868
AN:
67986
Other (OTH)
AF:
0.125
AC:
263
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
901
1802
2702
3603
4504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
228
456
684
912
1140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.139
Hom.:
639
Bravo
AF:
0.126
Asia WGS
AF:
0.0770
AC:
272
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 25% of patients studied by a panel of primary immunodeficiencies. Number of patients: 24. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.6
DANN
Benign
0.77
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2233417; hg19: chr14-35872094; COSMIC: COSV53751730; API